The 8k dated March 11, 2008 for Targeted Genetics sure makes
it look like they're wrapping things up over there. I hope the
death and disability stuff is just standard. There is provided
a termination payment of two times the "Executive’s annual
base salary in effect immediately prior to the date that
either a Change in Control shall occur" --plus some add ons.
I just skimmed it.
Here are some links for old time sake
Testimony of H. Stewart Parker Feb 2nd, 2000
bio.org
Included in the Forbes biotech all stars
forbes.com
the shareprice
finance.yahoo.com
Current marketcap of TGEN is down to $18M. I saw Parker years
ago in Seattle at one of those biotech investor shows. Bought
shares, attended an annual meeting or two. I always thought
they were tackling some very hard problems with limited chance
of success, but at least it seemed a very honest effort;
cystic fibrosis, cancer, HIV, and of course the more recent
attempt at arthritis which had some big ups and downs. The AAV
delivery method sounded like it had a chance of a first
success in 'gene therapy'. I never went for the real scammy
biotechs like the stem cell companies and such that were
clearly trying to generate hype and sell shares, although
arguably gene therapy was a bit out there too. Anyway, this
certainly hasn't been a good investment--they sold a lot of
shares over the years. Probably wasn't even a good
speculation--very few chances for even the traders to
made money in the stock, I've done very poorly on TGEN.
"Targeted Genetics gives Q4 and 2007 financial results on
Tuesday, March 25, 2008. There is a webcast at 7:30 a.m.
Pacific Time. You may access the live webcast via the "Events"
section found on the homepage of the Company's website at
www.targetedgenetics.com or via telephone at 800.240.4186"
With the marketcap of only $18m, and probably not more than
a year of cash on hand, I will be listening in for signs
that tgen is going to allow a bigger player to take over
their biotech projects. It sure seems like their expertise
with aav is an asset, and maybe their patents and such
have some value. |
